Agenus surges after securing up to $340M in financing to fund its phase III ROBBIN colon cancer study and extend its cash ...
Ewingella americana bacteria from frog guts cleared colorectal tumors in every treated mouse with one IV dose, outperforming ...
Agenus is redirecting its Phase 3 colon-cancer strategy. The biotech company said on July 13 that it will stop providing financial support for its BATTMAN study and make ROBBIN, a planned Phase 3 ...
The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...
Discover which colon cancer foods raise your risk and which protect your colon, backed by 2025–2026 research on fiber, red ...
A microscopic parasite is making thousands of Americans sick this summer, and public health officials are still figuring out ...
University of San Francisco, Health launched a program in March dedicated to understanding and treating colon cancer in young ...
Agenus has lined up as much as $340 million through an equity raising to finance a planned late-stage trial of its colon cancer treatment. The Lexington, Mass., immuno-oncology company said Monday it ...
More people are focusing on their gut health as colorectal cancer rises among young adults and personalized gut microbiome ...
A Central Texas man is asking for help finding a man he believes saved his life by encouraging him to get a cancer screening.